NATCO PHARMA LIMITED

Insiders NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Market Closed - NSE India S.E. Other stock markets 05:13:52 15/05/2024 pm IST			5-day change	1st Jan Change
982.9 ^INR	-0.71%		-0.21%	+21.14%

08/05	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT
08/05	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NATCO Pharma Limited Announces Board Appointments	27/03	CI
NATCO Pharma Limited Announces Executive Changes	31/22/31	CI
NATCO Pharma Limited Announces Board Changes	14/22/14	CI
NATCO Pharma Limited Announces the Reconstituted Committees of the Board	11/21/11	CI
NATCO Pharma Limited Appoints Leela Digumarti as Member of Corporate Social Responsibility Committee and Compensation Committee	12/20/12	CI
NATCO Pharma Limited Announces Board Changes	23/18/23	CI
Natco Pharma Limited Announces Board Resignations	07/17/07	CI
Natco Pharma Limited Approves Interim Dividend for the Year 2015-2016; Approves Appointment of S. V. V. N. Appa Rao as Chief Financial Officer	11/16/11	CI
Natco Pharma Limited Announces Board Appointments	11/15/11	CI
Natco Pharma Limited Announces Management Appointments	12/14/12	CI
Natco Pharma Limited Announces Demise of P. Bhaskara Narayana, Director and Chief Financial Officer	23/14/23	CI
Natco Pharma Appoints T V Rao as Additional Director	26/14/26	CI
Natco Pharma Limited Announces Board Changes	13/14/13	CI
Natco Pharma Limited Announces Redesignation of M. Adinarayana as Company Secretary & Vice President (Legal & Corporate Affairs)	20/13/20	CI
Jasti Sambasiva Rao Resigns as Director of Natco Pharma Limited	30/13/30	CI
Natco Pharma Limited Approves Re-Designation of Mr. Rajeev Nannapaneni as Vice Chairman & CEO	29/12/29	CI
Natco Pharma Limited Appoints Nominee Director	09/12/09	CI
Natco Pharma Limited Appoints Nitin Deshmukh as Additional Director	13/12/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW